| The new cell culture smallpox vaccine should be offered to the general population. | |
| | |
MedLine Citation:
|
PMID: 12516058 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A series of major factors must be weighed in deciding whether or not, and to what extent, a particular country should consider pre-exposure vaccination for smallpox. These include the risk of a bioterrorist attack using smallpox, the risk of secondary spread from another country, the risks and benefits of vaccination, the effectivenes s of vaccination pre- and post-exposure, the prevalence of immunocompromised persons, the capacity of the medical care delivery system and the wealth of a nation. We review here the issues and variables relevant for policy making, propose a framework for country-specific decision making and suggest the World Health Organization has a key role to play, particularly with regard to lower-income countries. In doing so, we support the proposition. |
| | |
Authors:
|
William Bicknell; Kenneth James |
Related Documents
:
|
22069498 - Capsomer vaccines protect mice from vaginal challenge with human papillomavirus. 2723058 - Acquired c1 inhibitor (c1-inh) deficiency type ii. replacement therapy with c1-inh and ... 10879368 - Sterilizing vaccines or the politics of the womb: retrospective study of a rumor in cam... 21692708 - Colorectal cancer vaccines in clinical trials. 22365398 - Effect of aluminum hydroxide adjuvant on the immunogenicity of the 2009 pandemic influe... 22246478 - Increasing fear of adverse effects drops intention to vaccinate after the introduction ... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Reviews in medical virology Volume: 13 ISSN: 1052-9276 ISO Abbreviation: Rev. Med. Virol. Publication Date: 2003 Jan-Feb |
Date Detail:
|
Created Date: 2003-01-07 Completed Date: 2003-03-13 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 9112448 Medline TA: Rev Med Virol Country: England |
Other Details:
|
Languages: eng Pagination: 5-15 Citation Subset: IM |
Copyright Information:
|
Copyright 2003 John Wiley & Sons, Ltd. |
Affiliation:
|
Department of International Health, School of Public Health, Boston University, USA. wbicknel@bu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bioterrorism* Humans Mass Vaccination / methods* Public Health* Smallpox / epidemiology, prevention & control* Smallpox Vaccine / administration & dosage*, adverse effects, immunology, standards United States / epidemiology World Health Organization |
| Chemical | |
Reg. No./Substance:
|
0/Smallpox Vaccine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
Next Document: The new cell culture smallpox vaccine should not be offered to the general population.